New Effective Targets

Sunil Verma, MD, MSEd, FRCPC
Video Categories: ESMO 2016

Sunil Verma, MD, MSEd, FRCPC discusses new classes of therapies for HR+ Breast Cancer.

January 20, 2016

How to Identify a Cancer Stem Cell

Dr Wainberg and Dr Gerson discuss how biomarkers may help identify cancer stem cells.

March 31, 2015

Ibrutinib and ABT199 for CLL

Jennifer R. Brown, MD, PhD, at Dana-Farber Cancer Institute in Boston, discusses what she believes are the most important items coming out of ASH for CLL this year. She mentions excellent study results being presented about the drugs ibrutinib and ABT199.